ArticleFrontiers in cardiovascular medicine2023

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).

Yasutaka Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.